Stay updated on Nivolumab and Urelumab in Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page.

Latest updates to the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This is a metadata/version update and does not alter study data or content.SummaryDifference0.1%

- Check14 days agoChange DetectedNew milestone dates were added and older dates removed in the Study Record Dates section, updating the trial's projected completion timeline.SummaryDifference0.3%

- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check43 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3. This appears to be an internal maintenance update with no changes to the study content or user-facing features.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision: v3.4.2 is now displayed and older notices about funding lapse and a previous revision (v3.4.1) were removed; this is a minor maintenance update that does not affect the study details or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check78 days agoChange DetectedAdded a site-wide notice about government funding and site operations. Updated the page revision to v3.4.1 and removed the previous v3.4.0 revision.SummaryDifference0.4%

Stay in the know with updates to Nivolumab and Urelumab in Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page.